The human beta 3-adrenergic receptor: relationship with atypical receptors.
Atypical beta-adrenergic receptors (beta AR), different from beta 1 and beta 2ARs, have been suggested to modulate energy expenditure. We have characterized a gene coding for a third human beta AR, beta 3AR, whose sequence is 402 amino acids long and is 50.7% and 45.5% homologous to that of the human beta 1 and beta 2AR, respectively. The KD of [125I]-iodocyanopindolol for beta 3AR is 10-fold higher than for beta 1 or beta 2AR. The receptor has an apparent molecular weight of 65,000. Agonists for the beta 3AR induce cyclic AMP accumulation. Among 11 beta antagonists tested, only ICI118551 and CGP20712A, previously classified as, respectively, beta 1 and beta 2 selective, inhibit this effect. The beta 1 and beta 2 antagonists pindolol, oxprenolol, and CGP12177 are agonists of the beta 3AR. The potency order of beta agonists at beta 3 sites correlates with that for stimulation of lipolysis in rat fat tissues. Moreover, because beta 3AR mRNA was detected in rodent adipose tissues, liver, and muscle, we propose that the beta 3AR participates to the control by catecholamines of energy expenditure.
Emorine
L J
LJ
Laboratoire d'Immmuno-Pharmacologie Moléculaire CNRS, Université Paris VII, France.
Fève
B
B
Pairault
J
J
Briend-Sutren
M M
MM
Nahmias
C
C
Marullo
S
S
Delavier-Klutchko
C
C
Strosberg
D A
DA
D000595:Amino Acid Sequence; D000818:Animals; D004734:Energy Metabolism; D014644:Genetic Variation; D006801:Humans; D008969:Molecular Sequence Data; D011943:Receptors, Adrenergic, beta / Q000737:chemistry / Q000235:genetics / Q000502:physiology*
D011943:Receptors, Adrenergic, beta